Patient Guide: Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 10 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04838444
Status: ACTIVE_NOT_RECRUITING
Condition: Chikungunya Virus Infection
Phase: PHASE3

Where You Can Participate

This study is available at 10 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Hallandale Beach, Florida
  • • Chicago, Illinois
  • • And 7 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553) - Join Clinical Trial NCTNCT04838444

How to Join This Clinical Trial - NCTNCT04838444

Learn how to participate in this PHASE3 trial studying an investigational therapy for Chikungunya Virus Infection. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chikungunya Virus Infection. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chikungunya Virus Infection
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04838444 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 10 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85020 - United States

Status: Contact for availability

Clinical Research Site

Hallandale Beach, Florida 33090 - United States

Status: Contact for availability

Clinical Research Site

Chicago, Illinois 60602 - United States

Status: Contact for availability

Clinical Research Site

Lexington, Kentucky 40509 - United States

Status: Contact for availability

Clinical Research Site

Grand Island, Nebraska 68803 - United States

Status: Contact for availability

Clinical Research Site

Omaha, Nebraska 68134 - United States

Status: Contact for availability

Clinical Research Site

Knoxville, Tennessee 37920 - United States

Status: Contact for availability

Clinical Research Site

Austin, Texas 78759 - United States

Status: Contact for availability

Clinical Research Site

West Jordan, Utah 84088 - United States

Status: Contact for availability

Clinical Research Site

Norfolk, Virginia 23502 - United States

Status: Contact for availability

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Chikungunya Virus Infection:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships